Synapsoft logo
AI Insights from Disclosures
Searching...
HANALL BIOPHARMA CO.,LTD 009420
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
HANALL BIOPHARMA CO.,LTD has contributed to improving public health by manufacturing and selling various pharmaceutical products in the domestic pharmaceutical market since its establishment in 1973, and was listed on the Korea Exchange in 1989. The company's main business is the research and development, manufacture, and sale of synthetic and biopharmaceutical drugs, with its R&D focused on developing biologic new drugs in areas such as autoimmune diseases, eye diseases, cancer, and neurological diseases.
Representative Director 박수진,박승국(공동대표이사)
Founded November 20, 1973
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 16411-0000397
Business number 306-81-05479
Phone Number 042-932-5997
Fax Number 024141950
Company Address 43 Sangseodang 1-gil, Daedeok-gu, Daejeon
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant